ALK	Anaplastic lymphoma kinase
ccRCC	Clear cell renal cell carcinoma
CI	Confidence interval
EGFR	Epidermal growth factor receptor
FH	Fumarate hydratase
HR	Hazard ratio
ICI	Immune checkpoint inhibitor
IHC	Immunohistochemistry
mOS	Median overall survival
mPFS	Median progression-free survival
mTOR	Mammalian target of rapamycin
nccRCC	Non-clear cell renal cell carcinoma
ORR	Overall response rate
OS	Overall survival
PARPi	Poly ADP ribose polymerase inhibitor
RCC	Renal cell carcinoma
SDH	Succinate Dehydrogenase
SOC	Standard of Care
TKI	Tyrosine kinase inhibitor
VEGFR	Vascular endothelial growth factor receptor
WHO	World Health Organization